Wedbush Securities’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,500
| Closed | -$30K | – | 1024 |
|
|
2019
Q3 | $30K | Buy |
14,500
+6,000
| +71% | +$12.4K | ﹤0.01% | 962 |
|
|
2019
Q2 | $40K | Buy |
+8,500
| New | +$40K | ﹤0.01% | 958 |
|
|
2018
Q1 | – | Sell |
-1,500
| Closed | -$10K | – | 876 |
|
|
2017
Q4 | $10K | Sell |
1,500
-800
| -35% | -$5.33K | ﹤0.01% | 850 |
|
|
2017
Q3 | $13K | Hold |
2,300
| – | – | ﹤0.01% | 829 |
|
|
2017
Q2 | $19K | Buy |
+2,300
| New | +$19K | ﹤0.01% | 826 |
|
|
2017
Q1 | – | Sell |
-1,800
| Closed | -$8K | – | 872 |
|
|
2016
Q4 | $8K | Sell |
1,800
-1,200
| -40% | -$5.33K | ﹤0.01% | 812 |
|
|
2016
Q3 | $17K | Buy |
3,000
+1,200
| +67% | +$6.8K | ﹤0.01% | 820 |
|
|
2016
Q2 | $12K | Hold |
1,800
| – | – | ﹤0.01% | 775 |
|
|
2016
Q1 | $15K | Hold |
1,800
| – | – | ﹤0.01% | 737 |
|
|
2015
Q4 | $18K | Buy |
+1,800
| New | +$18K | ﹤0.01% | 721 |
|